icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Tenofovir Alafenamide (TAF) in a Single-Tablet Regimen in Initial HIV-1 Therapy
 
 
  Combined Primary Results of Studies GS-US-292-0104 and GS-US-292-0111
 
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
 
Webcast http://www.croiwebcasts.org/console/player/25755?mediaType=slideVideo&
 
David Wohl1, Anton Pozniak2, Melanie Thompson3, Edwin DeJesus4, Daniel Podzamczer5, Jean-Michel Molina6, Gordon Crofoot7, Christian Callebaut8, Hal Martin8, Scott McCallister8
1University of North Carolina, Chapel Hill, NC; 2Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK; 3AIDS Research Consortium of Atlanta, Atlanta, GA; 4Orlando Immunology Center, Orlando, FL; 5Hospital Universitari de Bellvitge, Barcelona, Spain; 6Hopital Saint Louis, Paris, France; 7Gordon Crofoot Research, Houston, TX; 8Gilead Sciences, Foster City, CA Abstract 113LB

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif

CROI9.gif

CROI10.gif

CROI11.gif

CROI12.gif

CROI13.gif

CROI14.gif

CROI15.gif

CROI16.gif

CROI17.gif

CROI18.gif